| An NIR‐based PAT approach for real‐time control of loading in protein A chromatography in continuous manufacturing of monoclonal antibodies G Thakur, V Hebbi, AS Rathore Biotechnology and Bioengineering 117 (3), 673-686, 2020 | 56 | 2020 |
| Integrated continuous processing of proteins expressed as inclusion bodies: GCSF as a case study N Kateja, H Agarwal, V Hebbi, AS Rathore Biotechnology progress 33 (4), 998-1009, 2017 | 38 | 2017 |
| Process analytical technology implementation for protein refolding: GCSF as a case study V Hebbi, G Thakur, AS Rathore Biotechnology and bioengineering 116 (5), 1039-1052, 2019 | 24 | 2019 |
| Modeling and prediction of excipient and pH drifts during ultrafiltration/diafiltration of monoclonal antibody biotherapeutic for high concentration formulations V Hebbi, S Roy, AS Rathore, A Shukla Separation and Purification Technology 238, 116392, 2020 | 19 | 2020 |
| Automation of dead end filtration: an enabler for continuous processing of biotherapeutics G Thakur, V Hebbi, S Parida, AS Rathore Frontiers in Bioengineering and Biotechnology 8, 758, 2020 | 17 | 2020 |
| Near infrared spectroscopy as a PAT tool for monitoring and control of protein and excipient concentration in ultrafiltration of highly concentrated antibody formulations G Thakur, V Hebbi, AS Rathore International Journal of Pharmaceutics 600, 120456, 2021 | 14 | 2021 |
| Process analytical technology application for protein PEGylation using near infrared spectroscopy: G-CSF as a case study V Hebbi, G Thakur, AS Rathore Journal of biotechnology 325, 303-311, 2021 | 14 | 2021 |
| High performance liquid chromatography (HPLC) based direct and simultaneous estimation of excipients in biopharmaceutical products V Hebbi, S Chattopadhyay, AS Rathore Journal of Chromatography B 1117, 118-126, 2019 | 12 | 2019 |
| Glycosylation in mAb therapeutic products: analytical characterization and impact of process G Narula, V Hebbi, SK Singh, AS Rathore BioPharm, 21-34, 2016 | 11 | 2016 |
| Process for production and purification of lethal toxin neutralizing factor (LTNF) from E. coli and its economic analysis V Hebbi, K Pandi, D Kumar, C Komives, AS Rathore Journal of Chemical Technology & Biotechnology 93 (4), 959-967, 2018 | 9 | 2018 |
| A coiled flow inverter reactor for continuous refolding of denatured recombinant proteins and other mixing operations AS Rathore, KDP Nigam, M Pathak, H Agarwal, AK Sharma, N Kateja, ... Patent WO 2016116947, A1, 2016 | 5 | 2016 |
| Process analytical technology implementation for peptide manufacturing: cleavage reaction of recombinant lethal toxin neutralizing factor concatemer as a case study V Hebbi, D Kumar, AS Rathore Analytical chemistry 92 (8), 5676-5681, 2020 | 3 | 2020 |
| Practical Considerations of Capillary Electrophoresis– Mass Spectrometry for the Analysis of Biotherapeutics V Hebbi, SK Singh, AS Rathore, IS Krull. Biotechnology Today 34 (9), 1-7, 2016 | 3 | 2016 |
| Process intensification in peptide manufacturing: Recombinant lethal toxin neutralizing factor (rLTNF) as a case study V Hebbi, D Kumar, AS Rathore Process biochemistry 90, 193-203, 2020 | 1 | 2020 |
| NIR based real-time control of loading in Protein A chromatography AS Rathore, G Thakur, V Hebbi US Patent App. 17/436,599, 2022 | | 2022 |
| Ion Exchange Chromatographic Methods for Purification of Therapeutic Antibodies AS Rathore, V Hebbi Therapeutic Antibodies: Methods and Protocols, 179-186, 2022 | | 2022 |
| A system for real-time monitoring of protein and excipients TS Anurag Rathore, Vishwanath Hebbi, Garima Thakur WO Patent App. WO2021171310A1, 2021 | | 2021 |
| A system for real-time monitoring of protein and excipients A Rathore, V Hebbi, G Thakur, T SAVANE | | 2021 |
| Process for producing recombinant peptides CK Anurag Singh Rathore, Kathiresan Pandi, Vishwanath Hebbi, James Gomes WO Patent App. WO2020053875A1, 2020 | | 2020 |
| Development Of Monitoring And Control Strategies For Downstream Processes VS Hebbi Delhi, 2020 | | 2020 |
Anurag RathoreIndian Institute of Technology DelhiVerified email at biotechcmz.com
